new/2235-1-13033.php In a large randomized trial, bortezomib-melphalan-prednisone (VMP). 22, and 29 during cycles 5 to 9; and thalidomide 50 mg per day continuously. Recent larger population-based studies on patients with cancer showed. 2) Target Population a) Age >or= 18 years or legal age of consent per local. e) Creatinine clearance < 30 measured by 24-hour urine collection or. except for | ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|